Abstract
The pathogenesis of intracranial arterial aneurysms (AA) remains unclear, despite their clinical importance. An improved understanding of this disease is important in choosing therapeutic options. In addition to the “classical” berry-type aneurysm, there are various other types of intracranial AA such as infectious, dissecting or giant, partially-thrombosed aneurysms. From the clinician’s perspective, the hypothesis that some of these intracranial AA might be due to abluminal factors has been proposed for several years. Indeed, this hypothesis and the empirical use of anti-inflammatory drugs in giant intracranial aneurysms have been confirmed by recent studies reporting that an enzyme involved in the inflammatory cascade (5-lipoxygenase or 5-LO) promotes the pathogenesis of specific aneurysms in humans. 5-LO generates different forms of leukotrienes which are potent mediators of inflammation. Adventitial inflammation leads to a weakening of the media from the abluminal part of the vessel wall due to the release of proinflammatory factors that invade the media, thereby degrading the extracellular matrix, the elastic lamina of the vascular wall, and, finally, the integrity of the vessel lumen. This in turn results in a dilation of the vessel and aneurysm formation. Moreover, neoangiogenesis of vasa vasorum is found in close proximity to 5-LO activated macrophages. In addition to this biological cascade, we argue that repeated subadventitial haemorrhages from the new vasa vasorum play an important role in aneurysm pathogenesis, due to a progressive increase in size mediated by the apposition of new layers of intramural haematoma within the vessel wall. Intracranial giant AA can therefore be regarded as a proliferative disease of the vessel wall induced by extravascular activity. Considering certain aneurysmal vasculopathies as an abluminal disease might alter current therapeutic strategies. Therapy should not only be aimed at the intraluminal repair of the artery, but also cross the vessel wall to reach the vasa vasorum. Drug-eluting stents placed proximal to the lesion and targeted to the origin of the vasa vasorum could be considered as a potential future option. “Intelligent” MRI contrast agents (i.e., macrophage marking) could be used to detect vasa vasorum proliferation and weakening of the vessel wall in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Inci S, Spetzler RF (2000) Intracranial aneurysms and arterial hypertension: a review and hypothesis. Surg Neurol 53:530–540 (discussion 540–532)
Ferguson GG (1972) Physical factors in the initiation, growth, and rupture of human intracranial saccular aneurysms. J Neurosurg 37:666–677
Stehbens WE (1989) Etiology of intracranial berry aneurysms. J Neurosurg 70:823–831
Stehbens WE (1990) Pathology and pathogenesis of intracranial berry aneurysms. Neurol Res 12:29–34
Lasjaunias P (2000) From aneurysm to aneurysmal vasculopathies. Oper Tech Neurosurg 3:160–165
Schubiger O, Valavanis A, Hayek J (1980) Computed tomography in cerebral aneurysms with special emphasis on giant intracranial aneurysms. J Comput Assist Tomogr 4:24–32
Schubiger O, Valavanis A, Wichmann W (1987) Growth-mechanism of giant intracranial aneurysms; demonstration by CT and MR imaging. Neuroradiology 29:266–271
Zhao L, Moos MP, Grabner R et al (2004) The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10:966–973
Berenstein A, Lasjaunias P, TerBrugge KG (2004) Surgical neuroangiography, vol 2.1. Springer, Berlin Heidelberg New York
Aydin F (1998) Do human intracranial arteries lack vasa vasorum? A comparative immunohistochemical study of intracranial and systemic arteries. Acta Neuropathol (Berl) 96:22–28
Connolly ES Jr, Huang J, Goldman JE, Holtzman RN (1996) Immunohistochemical detection of intracranial vasa vasorum: a human autopsy study. Neurosurgery 38:789–793
Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–575
Spanbroek R, Grabner R, Lotzer K et al (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100:1238–1243
Sinha S, Frishman WH (1998) Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target. J Clin Pharmacol 38:1077–1088
Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110:625–632
Daugherty A, Cassis LA (2002) Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep 4:222–227
Kumamoto M, Nakashima Y, Sueishi K (1995) Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 26:450–456
Lotzer K, Spanbroek R, Hildner M et al (2003) Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 23:e32–e36
Palinski W (2004) Aneurysms: leukotrienes weaken aorta from the outside. Nat Med 10:896–898
Yasargil MG (1984) Clinical considerations, surgery of the intracranial aneurysms and results. Microneurosurgery, vols 1 and 2. Thieme, Stuttgart
Iihara K, Murao K, Sakai N et al (2003) Continued growth of and increased symptoms from a thrombosed giant aneurysm of the vertebral artery after complete endovascular occlusion and trapping: the role of vasa vasorum. Case report. J Neurosurg 98:407–413
Yonas H, Agamanolis D, Takaoka Y, White RJ (1977) Dissecting intracranial aneurysms. Surg Neurol 8:407–415
Stehbens WE (1998) Apoptosis and matrix vesicles in the genesis of arterial aneurysms of cerebral arteries. Stroke 29:1478–1480
Endo S, Nishijima M, Nomura H, Takaku A, Okada E (1993) A pathological study of intracranial posterior circulation dissecting aneurysms with subarachnoid hemorrhage: report of three autopsied cases and review of the literature. Neurosurgery 33:732–738
Dollery CM, Owen CA, Sukhova GK, Krettek A, Shapiro SD, Libby P (2003) Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation 107:2829–2836
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Stehbens WE (1999) Misconceptions of the pathology of intracranial arterial aneurysms. J Clin Pathol 52:708
Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Pratico D (2002) Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106:1282–1287
Blankenberg FG, Mari C, Strauss HW (2002) Development of radiocontrast agents for vascular imaging: progress to date. Am J Cardiovasc Drugs 2:357–365
Trivedi RA, JM UK-I, Graves MJ et al (2004) In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35:1631–1635
Corot C, Petry KG, Trivedi R et al (2004) Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 39:619–625
Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M (2003) Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation 107:1545–1549
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krings, T., Piske, R.L. & Lasjaunias, P.L. Intracranial arterial aneurysm vasculopathies: targeting the outer vessel wall. Neuroradiology 47, 931–937 (2005). https://doi.org/10.1007/s00234-005-1438-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-005-1438-9